Search Results
Found 1 results
510(k) Data Aggregation
(64 days)
The Zeus Scientific, Inc. Gliadin IgG ELISA test system is intended for the qualitative and quantitative determination of IgG-class antibodies to gliadin in human serum. The test system is intended to be used as an aid in the diagnosis of gastrointestinal disorders, mainly Coeliac Disease. This test is for in vitro diagnostic use.
Not Found
The provided text is a 510(k) clearance letter from the FDA for the "Gliadin IgG ELISA Test System." It confirms the device's substantial equivalence to legally marketed devices but does not include any study data, acceptance criteria, or performance metrics.
Therefore, I cannot provide the requested information. The document focuses on regulatory approval based on the device being substantially equivalent, rather than detailing the specifics of a clinical study or performance validation.
To answer your request, information regarding acceptance criteria and performance data would need to be found in the actual 510(k) submission document itself, which is not provided here.
Ask a specific question about this device
Page 1 of 1